Our triggered brand peptides offer advanced solutions for weight management and type 2 diabetes research. These synthetic peptides are designed to mimic natural hormones that regulate metabolism, appetite, and blood sugar levels.
The product line includes Semaglutide, Tirzepatide, Cagrilintide, and Retatrutide - all formulated as lyophilized powders with high purity levels. These peptides work through multiple mechanisms including slowing gastric emptying, stimulating insulin secretion, and promoting satiety.
Key benefits for research applications include glucose regulation, appetite suppression, and potential fat conversion effects. The peptides have shown promise in studies for reducing HbA1c, fasting glucose, and body weight in clinical models.
All products are manufactured under strict GMP conditions with comprehensive quality control. The lyophilized formulation ensures stability and convenient reconstitution for research purposes.